Skip to main
USPH
USPH logo

USPH Stock Forecast & Price Target

USPH Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 25%
Buy 75%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

US Physical Therapy Inc. has demonstrated a positive financial trajectory, highlighted by a sequential commercial pricing increase of 2.2%, indicating a solid demand for its services. The industrial injury prevention (IIP) segment reported remarkable revenue growth of 22.2% overall, with a substantial 18.4% increase when excluding contributions from mergers and acquisitions. This performance underscores the company's strong operational fundamentals and its ability to capitalize on multiple revenue streams from both physical therapy operations and industrial injury prevention services.

Bears say

US Physical Therapy has experienced a decline in a key financial metric, with an observed decrease of 0.6% to $83.95 from $84.46 in the comparable period a year ago, highlighting potential stagnation in revenue growth. The company has faced continuous reimbursement cuts over the past five years, culminating in a substantial $20 million headwind to profitability, which raises concerns about its financial sustainability. Additionally, the company's operational expenses have slightly exceeded estimates, with rent and clinic costs comprising 20.2% of revenue, further straining its profitability outlook.

USPH has been analyzed by 4 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 75% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of U.S. Physical Therapy and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About U.S. Physical Therapy (USPH) Forecast

Analysts have given USPH a Buy based on their latest research and market trends.

According to 4 analysts, USPH has a Buy consensus rating as of Oct 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $110.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $110.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

U.S. Physical Therapy (USPH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.